Marker Therapeutics, Inc. (MRKR)
0.8928
0.00 (0.00%)
USD |
NASDAQ |
Nov 06, 16:00
0.9166
+0.02
(+2.67%)
After-Hours: 20:00
Marker Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -154.4% |
| September 30, 2025 | -162.1% |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | -170.4% |
| September 30, 2024 | -119.8% |
| June 30, 2024 | -187.5% |
| March 31, 2024 | -192.3% |
| December 31, 2023 | -259.4% |
| September 30, 2023 | -1.16K% |
| June 30, 2023 | -537.4% |
| March 31, 2023 | -342.3% |
| December 31, 2022 | -400.9% |
| September 30, 2022 | -572.9% |
| June 30, 2022 | -1.17K% |
| March 31, 2022 | -1.03K% |
| December 31, 2021 | -786.3% |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | -1.36K% |
| March 31, 2020 | |
| December 31, 2019 | -2.38K% |
| Date | Value |
|---|---|
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -2.34K% |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | -2.18K% |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 21.97% |
| ACADIA Pharmaceuticals, Inc. | 15.64% |
| Alnylam Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -60.77% |
| Return on Assets | -49.70% |
| Return on Invested Capital | -60.77% |